AI assistant
ARIX BIOSCIENCE PLC Regulatory Filings 2022
4968_rns_2022-02-25_afb6ef9d-4e03-404f-bb8d-ad0f3fcc1bf4.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9131C
Arix Bioscience Plc
25 February 2022
25 February 2022
Arix Bioscience Plc (the "Company")
Closed Period Notification
In accordance with the provisions of the UK Market Abuse Regulation ("UK MAR"), the Company announces that it has today entered into a closed period which will remain in place until the Company publishes its annual financial results for the year ended 31 December 2021, with an expected publication date of early April, to be confirmed.
The Company confirms that it is satisfied that all inside information which the Directors and the Company may have had to the date of this announcement has been notified to a Regulatory Information Service. Accordingly, the Company is not prohibited from dealing in its own securities during this closed period. In the event that the Directors and the Company come into possession of any further insider information during the closed period, this will be notified to a Regulatory Information Service in accordance with UK MAR.
For and on behalf of the Company,
Deirdre Quinn
Derringtons Limited, Company Secretary
Enquiries: +44 (0) 20 8819 6486
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCMZGZZKKNGZZM